Literature DB >> 14603194

The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients.

Juan I Arcelus1, Joseph A Caprini, Manuel Monreal, Carmen Suárez, José González-Fajardo.   

Abstract

OBJECTIVE: To obtain a realistic overview of management and clinical outcomes of patients with venous thromboembolism (VTE) in Spain on the basis of data from a national multicenter registry.
METHODS: A prospective registry was initiated in Spain in March 2001. Data were collected from patients with objectively confirmed deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and entered into the online registry by physicians who were responsible for the management of these patients.
RESULTS: As of August 2002, 4011 patients with confirmed VTE were included in the registry: 60% with DVT, 23% with PE, and 17% with both DVT and PE. Diagnostic methods for VTE included compression ultrasonography (86%), venography (10%), V/Q lung scans (42%), computed tomography scan (28%), and pulmonary angiography (0.9%). D-dimer testing was performed in 61% of cases and was positive in 92% of patients with confirmed VTE. The majority of DVT (95%) were located in the lower extremities (82% proximal and 4% bilateral), while 4.8% were located in the upper extremities or neck veins. Most patients (90.5%) were admitted to hospital. In the acute phase, treatment consisted of low molecular weight heparin (LMWH) in 88%, unfractionated heparin (UFH) in 11%, and fibrinolysis in 0.8%. Cava filters were inserted in 2% of patients, mainly because of active bleeding (13%), increased hemorrhagic risk (38%), or recurrent VTE (29%). Absolute bed rest was recommended to 63% of patients. Secondary prevention of VTE included oral anticoagulants (75%) and LMWH (24.5%). Therapeutic compression stockings were prescribed to 53% of patients at the time of hospital discharge. Regarding the main clinical outcomes during an average (+/-SD) follow-up period of 156 +/- 95 days, 19% had adverse events: 12.5% of patients died, 5.5% had clinically confirmed VTE recurrence, and 9.8% suffered bleeding complications (44% with major bleeding).
CONCLUSIONS: This prospective observational multicenter registry provides a large database reflecting the actual day-to-day clinical practice regarding VTE management in a European country. The most important findings were the increasing use of spiral computed tomography for PE diagnosis, the unexpectedly high proportion of patients admitted to hospital despite the use of LMWH in almost 90% of cases in the acute phase, and the utilization of LMWH for secondary prevention in almost 25% of cases. On the other hand, this large-scale prospective registry permits on-line consultation of high-risk situations to assess how difficult cases were treated and what their outcomes were. This will provide a most useful tool for the practicing physician responsible for the management of VTE patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14603194     DOI: 10.1016/s0741-5214(03)00789-4

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  17 in total

1.  Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis.

Authors:  Payal Patel; Parth Patel; Meha Bhatt; Cody Braun; Housne Begum; Robby Nieuwlaat; Rasha Khatib; Carolina C Martins; Yuan Zhang; Itziar Etxeandia-Ikobaltzeta; Jamie Varghese; Hani Alturkmani; Waled Bahaj; Mariam Baig; Rohan Kehar; Ahmad Mustafa; Rakesh Ponnapureddy; Anchal Sethi; Merrill Thomas; David Wooldridge; Wendy Lim; Shannon M Bates; Eddy Lang; Grégoire Le Gal; Marc Righini; Wojtek Wiercioch; Holger J Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2020-06-23

2.  The AVAIL ME study: a multinational survey of VTE risk and prophylaxis.

Authors:  Ali T Taher; Joseph Aoun; Pascale Salameh
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

3.  Does supervised exercise after deep venous thrombosis improve recanalization of occluded vein segments? A randomized study.

Authors:  Nazim Isma; Ellinor Johanssson; Anna Björk; Ola Björgell; Fredrik Robertson; Ingrid Mattiasson; Anders Gottsäter; Bengt Lindblad
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

4.  Indications, applications, and outcomes of inferior vena cava filters for venous thromboembolism in Japanese patients.

Authors:  Yugo Yamashita; Takashi Unoki; Daisuke Takagi; Yasuhiro Hamatani; Mitsuru Ishii; Moritake Iguchi; Hisashi Ogawa; Nobutoyo Masunaga; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Masaharu Akao
Journal:  Heart Vessels       Date:  2015-07-02       Impact factor: 2.037

5.  Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism.

Authors:  Parth Patel; Payal Patel; Meha Bhatt; Cody Braun; Housne Begum; Robby Nieuwlaat; Rasha Khatib; Carolina C Martins; Yuan Zhang; Itziar Etxeandia-Ikobaltzeta; Jamie Varghese; Hani Alturkmani; Waled Bahaj; Mariam Baig; Rohan Kehar; Ahmad Mustafa; Rakesh Ponnapureddy; Anchal Sethi; Merrill Thomas; David Wooldridge; Wendy Lim; Shannon M Bates; Eddy Lang; Grégoire Le Gal; Linda B Haramati; Jeffrey Kline; Marc Righini; Wojtek Wiercioch; Holger Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-04-27

6.  Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms.

Authors:  Ram S Duriseti; Margaret L Brandeau
Journal:  Ann Emerg Med       Date:  2010-06-03       Impact factor: 5.721

Review 7.  [Treatment of deep vein thrombosis. When to use which substance?].

Authors:  R M Bauersachs
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

8.  Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.

Authors:  D P Cronin-Fenton; F Søndergaard; L A Pedersen; J P Fryzek; K Cetin; J Acquavella; J A Baron; H T Sørensen
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

9.  Hospitalization for venous thromboembolic disease management: a 10 years Registry in Buenos Aires, Argentina.

Authors:  Fernando Javier Vázquez; Maria Florencia Grande-Ratti; Maria Elena Zapiola; Diego Giunta; Maria Lourdes Posadas-Martinez
Journal:  J Thromb Thrombolysis       Date:  2021-04-26       Impact factor: 2.300

10.  Antithrombotic prophylaxis in the middle East.

Authors:  Samir Arnaout; Hanady R Samaha; Julien Succar; Imad Bou-Akl; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.